Veeva AI Launches to Revolutionize Life Sciences Applications with Artificial Intelligence
On April 29, 2025, Veeva Systems announced a groundbreaking initiative named Veeva AI, aimed at integrating artificial intelligence into its existing Vault platform and various applications. This innovative move is designed to bolster productivity for life sciences companies by automating critical sector-specific tasks, effectively transforming workflows in areas ranging from clinical research to commercial operations.
Veeva AI employs AI Agents and AI Shortcuts to revolutionize how users interact with Veeva applications. By introducing large language models (LLMs) into the existing applications, Veeva AI allows users to leverage AI Agents that are tailored to specific functions and responsibilities. These agents are not only context-aware, understanding the nuances of the Veeva ecosystem, but they also possess specific safeguards and direct access to application data, documents, and workflows, making them highly effective tools for enhancing efficiency in day-to-day operations.
The automation capabilities of the AI Agents enable users to configure them according to their unique business needs. Organizations can deploy existing agents provided by Veeva or develop custom AI Agents to achieve specific objectives. The interaction with these agents can occur through a user-friendly chatbot interface or can be integrated via the AI API, ensuring a seamless and intuitive user experience.
Veeva AI Shortcuts provide an additional layer of utility by allowing users to set up personal, AI-driven automation for frequent tasks. Whether it’s streamlining workflows or generating insights, these shortcuts empower users to enhance their daily productivity significantly.
In discussing the launch, Veeva’s CEO, Peter Gassner, emphasized that generative AI represents a transformative new computing paradigm which will enhance the productivity of knowledge workers across various industries. He mentioned, "Core applications deliver structured data, business rules, and workflows with the speed and reliability we expect from computers; however, generative AI can extract meaningful responses and insights from ambiguous situations rooted in language and broad knowledge. The seamless integration of core applications with generative AI will yield significant productivity benefits."
Veeva AI is designed to be independent of LLMs, compatible with most major models on the market. This means clients have the flexibility to either utilize a model provided by Veeva or configure the system to use a customer-specific LLM. Importantly, Veeva AI maintains strict data security protocols regardless of the chosen implementation, ensuring client information remains protected at all times.
Veeva understands that its applications are integral to the critical processes within the life sciences sector, impacting everything from clinical trials to sales strategies. The added functionality of AI is intended to not only increase productivity but also to expedite the delivery of therapies to patients in need. Gassner reaffirmed, "Veeva AI will assist in simplifying the adoption of AI across life sciences companies of all sizes, making the technology safe and compliant with industry standards."
The first version of Veeva AI is scheduled for release in December 2025 and will be available under a reasonable subscription license model for Vault users. This pricing strategy is tailored to encourage broad and thoughtful adoption across the life sciences community.
About Veeva Systems: Established as a leader in cloud software solutions for life sciences, Veeva Systems is dedicated to product innovation and ensuring client success. With over 1,000 clients ranging from major biopharmaceutical companies to emerging biotech firms, Veeva continues to emphasize sustainability by prioritizing the interests of all stakeholders involved. More information about Veeva’s commitments and offerings can be found at veeva.com/eu.
The announcement also includes forward-looking statements regarding the expected outcomes of Veeva’s products, cautioning that actual results may vary significantly due to various inherent risks and uncertainties, as detailed in their recent SEC filings.
Veeva AI employs AI Agents and AI Shortcuts to revolutionize how users interact with Veeva applications. By introducing large language models (LLMs) into the existing applications, Veeva AI allows users to leverage AI Agents that are tailored to specific functions and responsibilities. These agents are not only context-aware, understanding the nuances of the Veeva ecosystem, but they also possess specific safeguards and direct access to application data, documents, and workflows, making them highly effective tools for enhancing efficiency in day-to-day operations.
The automation capabilities of the AI Agents enable users to configure them according to their unique business needs. Organizations can deploy existing agents provided by Veeva or develop custom AI Agents to achieve specific objectives. The interaction with these agents can occur through a user-friendly chatbot interface or can be integrated via the AI API, ensuring a seamless and intuitive user experience.
Veeva AI Shortcuts provide an additional layer of utility by allowing users to set up personal, AI-driven automation for frequent tasks. Whether it’s streamlining workflows or generating insights, these shortcuts empower users to enhance their daily productivity significantly.
In discussing the launch, Veeva’s CEO, Peter Gassner, emphasized that generative AI represents a transformative new computing paradigm which will enhance the productivity of knowledge workers across various industries. He mentioned, "Core applications deliver structured data, business rules, and workflows with the speed and reliability we expect from computers; however, generative AI can extract meaningful responses and insights from ambiguous situations rooted in language and broad knowledge. The seamless integration of core applications with generative AI will yield significant productivity benefits."
Veeva AI is designed to be independent of LLMs, compatible with most major models on the market. This means clients have the flexibility to either utilize a model provided by Veeva or configure the system to use a customer-specific LLM. Importantly, Veeva AI maintains strict data security protocols regardless of the chosen implementation, ensuring client information remains protected at all times.
Veeva understands that its applications are integral to the critical processes within the life sciences sector, impacting everything from clinical trials to sales strategies. The added functionality of AI is intended to not only increase productivity but also to expedite the delivery of therapies to patients in need. Gassner reaffirmed, "Veeva AI will assist in simplifying the adoption of AI across life sciences companies of all sizes, making the technology safe and compliant with industry standards."
The first version of Veeva AI is scheduled for release in December 2025 and will be available under a reasonable subscription license model for Vault users. This pricing strategy is tailored to encourage broad and thoughtful adoption across the life sciences community.
About Veeva Systems: Established as a leader in cloud software solutions for life sciences, Veeva Systems is dedicated to product innovation and ensuring client success. With over 1,000 clients ranging from major biopharmaceutical companies to emerging biotech firms, Veeva continues to emphasize sustainability by prioritizing the interests of all stakeholders involved. More information about Veeva’s commitments and offerings can be found at veeva.com/eu.
The announcement also includes forward-looking statements regarding the expected outcomes of Veeva’s products, cautioning that actual results may vary significantly due to various inherent risks and uncertainties, as detailed in their recent SEC filings.
Topics Business Technology）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.